|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.06 USD | -.--% |
|
+2.00% | -4.97% |
| 05-14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
| 05-14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Ovid Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 0.148 million compared to USD 0.066 million a year ago. Net loss was USD 11.69 million compared to USD 13.36 million a year ago.
Basic loss per share from continuing operations was USD 0.17 compared to USD 0.19 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.19 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.97% | 217M | |
| +11.91% | 114B | |
| +11.60% | 105B | |
| -4.68% | 23.83B | |
| -0.82% | 21.73B | |
| -10.12% | 18.1B | |
| -42.12% | 16.34B | |
| -17.47% | 16.13B | |
| +2.77% | 13.75B | |
| +34.58% | 11.76B |
OVID THERAPEUTICS INC. 
